Cargando…
Secretion of soluble complement inhibitors factor H and factor H-like protein (FHL-1) by ovarian tumour cells
We observed that the soluble complement regulators factor H and factor H-like protein were abundantly present in ascites samples as well as in primary tumours of patients with ovarian cancer. RT–PCR and immunoblotting analyses showed that the two complement inhibitors were constitutively produced by...
Autores principales: | Junnikkala, S, Hakulinen, J, Jarva, H, Manuelian, T, Bjørge, L, Bützow, R, Zipfel, P F, Meri, S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376183/ https://www.ncbi.nlm.nih.gov/pubmed/12402151 http://dx.doi.org/10.1038/sj.bjc.6600614 |
Ejemplares similares
-
Ascitic complement system in ovarian cancer
por: Bjørge, L, et al.
Publicado: (2005) -
Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours
por: Lantuejoul, S, et al.
Publicado: (2004) -
FGFR3IIIS: a novel soluble FGFR3 spliced variant that modulates growth is frequently expressed in tumour cells
por: Sturla, L-M, et al.
Publicado: (2003) -
The tumour–stromal interaction between intratumoral c-Met and stromal hepatocyte growth factor associated with tumour growth and prognosis in non-small-cell lung cancer patients
por: Masuya, D, et al.
Publicado: (2004) -
ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma
por: Grützmann, R, et al.
Publicado: (2004)